Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
WHO Country Office for India, New Delhi, India.
Pulmonology. 2022 Nov-Dec;28(6):449-453. doi: 10.1016/j.pulmoe.2020.10.007. Epub 2020 Dec 5.
A tertiary care hospital in North India.
Tuberculosis (TB) remains a major public health problem in developing countries. The diagnosis of tuberculosis is still challenging in primary care settings in endemic countries like India. WHO has endorsed loop mediated isothermal amplification assay (LAMP) for TB as a replacement for smear microscopy for peripheral settings, however, more data is required to establish the specificity of this modality for the diagnosis of TB. In this study we aim to determine the diagnostic accuracy of the TB-LAMP assay in pulmonary tuberculosis.
A total of 236 patients (117 cases suspected of TB and 119 patients with non-TB pulmonary disease) were enrolled between February to July, 2018. Microbiological workups consisting of mycobacterial smear microscopy, culture, Xpert MTB/Rif and TB-LAMP were performed.
From 236 samples, 18 (7.6%) were excluded from the study. TB-LAMP and Xpert MTB/RIF were positive in 46 (21.1%) and 49 (22.5%) of the samples, respectively. The sensitivity of Xpert MTB/RIF and TB-LAMP, when culture was taken as a reference standard, was 90% (95%CI: 78.2-96.7) and 82% (95%CI: 68.6...91.4), respectively. The specificity, positive predictive value (PPV), and negative predictive value (NPV) of TB-LAMP assay were 96.8% (95%CI: 92.8...98.9), 89.1% (95%CI: 77.4...95.2), and 94.4% (95%CI: 90.4...96.5), respectively.
The TB-LAMP assay showed a good specificity and sensitivity for detection ofM. tuberculosis in adults, however, for programmatic implementation, more studies are required to be conducted at peripheral level healthcare settings.
印度北部的一家三级保健医院。
结核病(TB)仍然是发展中国家的一个主要公共卫生问题。在印度等流行国家的基层医疗环境中,结核病的诊断仍然具有挑战性。世界卫生组织(WHO)已经认可环介导等温扩增检测(LAMP)作为替代涂片显微镜检查用于外周环境的检测方法,然而,还需要更多的数据来确定该方法对结核病诊断的特异性。在这项研究中,我们旨在确定 LAMP 检测在肺结核中的诊断准确性。
共纳入 2018 年 2 月至 7 月期间的 236 例患者(117 例疑似结核病和 119 例非结核性肺病患者)。进行了包括分枝杆菌涂片显微镜检查、培养、Xpert MTB/Rif 和 TB-LAMP 在内的微生物学检查。
在 236 个样本中,有 18 个(7.6%)被排除在研究之外。TB-LAMP 和 Xpert MTB/RIF 在 46 个(21.1%)和 49 个(22.5%)样本中呈阳性。以培养作为参考标准时,Xpert MTB/RIF 和 TB-LAMP 的敏感性分别为 90%(95%CI:78.2-96.7)和 82%(95%CI:68.6-91.4)。TB-LAMP 检测的特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为 96.8%(95%CI:92.8-98.9)、89.1%(95%CI:77.4-95.2)和 94.4%(95%CI:90.4-96.5)。
LAMP 检测在成人中检测结核分枝杆菌具有良好的特异性和敏感性,然而,为了在规划层面实施,还需要在基层医疗环境中开展更多的研究。